The burden of atopic dermatitis in adults in Italy

Paolo Sciattella, Giovanni Pellacani, Paolo D Pigatto, Annalisa Patrizi, Ketty Peris, Piergiacomo Calzavara-Pinton, Giampiero Girolomoni, Elena P Lanati, Anna D'ausilio, Francesco S Mennini

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Moderate-to-severe atopic dermatitis (AD) generates a considerable consumption of healthcare resources and significant economic consequences for the patients and their families, healthcare systems (NHS) and society. Several studies on the burden of AD in paediatric patients are available in literature, while data in adults is scant. The purpose of this study was to estimate the direct and indirect costs of moderate to severe AD in adult patients in Italy.

METHODS: Patients with Eczema Area and Severity Index (EASI) score >20 were included in a multicentre, observational study conducted in six outpatient dermatology clinics throughout the national territory. Data were retrospectively gathered through a case report form investigating healthcare resources consumption, out-of-pocket expenses and patients' and caregivers' productivity loss. Descriptive statistics was used to illustrate data. Univariate generalized linear model with gamma distribution and identity function link was used to describe association between costs and disease severity.

RESULTS: A total of 50 patients with a diagnosis of moderate-to-severe DA (EASI score ≥ 20), equal to 89% of the total, were included in the analysis. The total annual burden of the disease, direct and indirect costs, amounted to € 4,284 per patient; 19.3% accounted for direct medical costs, 19.9% for direct non-medical and 60.8% for indirect costs due to productivity loss.

CONCLUSIONS: Moderate-to-severe AD in adults represents an important cost for the society imposing a high financial burden for the NHS, but even more for patients and caregivers. Results from this study may support identification of potential factors impacting on the choice of new therapeutic options to improve the clinical and economic management of this devastating disease.

Original languageEnglish
JournalGiornale Italiano di Dermatologia e Venereologia
DOIs
Publication statusE-pub ahead of print - Sep 12 2019

Fingerprint

Atopic Dermatitis
Italy
Costs and Cost Analysis
Eczema
Delivery of Health Care
Caregivers
Economics
Cost of Illness
Disease Management
Health Expenditures
Dermatology
Ambulatory Care Facilities
Multicenter Studies
Observational Studies
Linear Models
Pediatrics

Cite this

The burden of atopic dermatitis in adults in Italy. / Sciattella, Paolo; Pellacani, Giovanni; Pigatto, Paolo D; Patrizi, Annalisa; Peris, Ketty; Calzavara-Pinton, Piergiacomo; Girolomoni, Giampiero; Lanati, Elena P; D'ausilio, Anna; Mennini, Francesco S.

In: Giornale Italiano di Dermatologia e Venereologia, 12.09.2019.

Research output: Contribution to journalArticle

Sciattella, P, Pellacani, G, Pigatto, PD, Patrizi, A, Peris, K, Calzavara-Pinton, P, Girolomoni, G, Lanati, EP, D'ausilio, A & Mennini, FS 2019, 'The burden of atopic dermatitis in adults in Italy', Giornale Italiano di Dermatologia e Venereologia. https://doi.org/10.23736/S0392-0488.19.06430-7
Sciattella, Paolo ; Pellacani, Giovanni ; Pigatto, Paolo D ; Patrizi, Annalisa ; Peris, Ketty ; Calzavara-Pinton, Piergiacomo ; Girolomoni, Giampiero ; Lanati, Elena P ; D'ausilio, Anna ; Mennini, Francesco S. / The burden of atopic dermatitis in adults in Italy. In: Giornale Italiano di Dermatologia e Venereologia. 2019.
@article{fead9e205046409089db6fbeca7dcc97,
title = "The burden of atopic dermatitis in adults in Italy",
abstract = "BACKGROUND: Moderate-to-severe atopic dermatitis (AD) generates a considerable consumption of healthcare resources and significant economic consequences for the patients and their families, healthcare systems (NHS) and society. Several studies on the burden of AD in paediatric patients are available in literature, while data in adults is scant. The purpose of this study was to estimate the direct and indirect costs of moderate to severe AD in adult patients in Italy.METHODS: Patients with Eczema Area and Severity Index (EASI) score >20 were included in a multicentre, observational study conducted in six outpatient dermatology clinics throughout the national territory. Data were retrospectively gathered through a case report form investigating healthcare resources consumption, out-of-pocket expenses and patients' and caregivers' productivity loss. Descriptive statistics was used to illustrate data. Univariate generalized linear model with gamma distribution and identity function link was used to describe association between costs and disease severity.RESULTS: A total of 50 patients with a diagnosis of moderate-to-severe DA (EASI score ≥ 20), equal to 89{\%} of the total, were included in the analysis. The total annual burden of the disease, direct and indirect costs, amounted to € 4,284 per patient; 19.3{\%} accounted for direct medical costs, 19.9{\%} for direct non-medical and 60.8{\%} for indirect costs due to productivity loss.CONCLUSIONS: Moderate-to-severe AD in adults represents an important cost for the society imposing a high financial burden for the NHS, but even more for patients and caregivers. Results from this study may support identification of potential factors impacting on the choice of new therapeutic options to improve the clinical and economic management of this devastating disease.",
author = "Paolo Sciattella and Giovanni Pellacani and Pigatto, {Paolo D} and Annalisa Patrizi and Ketty Peris and Piergiacomo Calzavara-Pinton and Giampiero Girolomoni and Lanati, {Elena P} and Anna D'ausilio and Mennini, {Francesco S}",
year = "2019",
month = "9",
day = "12",
doi = "10.23736/S0392-0488.19.06430-7",
language = "English",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",

}

TY - JOUR

T1 - The burden of atopic dermatitis in adults in Italy

AU - Sciattella, Paolo

AU - Pellacani, Giovanni

AU - Pigatto, Paolo D

AU - Patrizi, Annalisa

AU - Peris, Ketty

AU - Calzavara-Pinton, Piergiacomo

AU - Girolomoni, Giampiero

AU - Lanati, Elena P

AU - D'ausilio, Anna

AU - Mennini, Francesco S

PY - 2019/9/12

Y1 - 2019/9/12

N2 - BACKGROUND: Moderate-to-severe atopic dermatitis (AD) generates a considerable consumption of healthcare resources and significant economic consequences for the patients and their families, healthcare systems (NHS) and society. Several studies on the burden of AD in paediatric patients are available in literature, while data in adults is scant. The purpose of this study was to estimate the direct and indirect costs of moderate to severe AD in adult patients in Italy.METHODS: Patients with Eczema Area and Severity Index (EASI) score >20 were included in a multicentre, observational study conducted in six outpatient dermatology clinics throughout the national territory. Data were retrospectively gathered through a case report form investigating healthcare resources consumption, out-of-pocket expenses and patients' and caregivers' productivity loss. Descriptive statistics was used to illustrate data. Univariate generalized linear model with gamma distribution and identity function link was used to describe association between costs and disease severity.RESULTS: A total of 50 patients with a diagnosis of moderate-to-severe DA (EASI score ≥ 20), equal to 89% of the total, were included in the analysis. The total annual burden of the disease, direct and indirect costs, amounted to € 4,284 per patient; 19.3% accounted for direct medical costs, 19.9% for direct non-medical and 60.8% for indirect costs due to productivity loss.CONCLUSIONS: Moderate-to-severe AD in adults represents an important cost for the society imposing a high financial burden for the NHS, but even more for patients and caregivers. Results from this study may support identification of potential factors impacting on the choice of new therapeutic options to improve the clinical and economic management of this devastating disease.

AB - BACKGROUND: Moderate-to-severe atopic dermatitis (AD) generates a considerable consumption of healthcare resources and significant economic consequences for the patients and their families, healthcare systems (NHS) and society. Several studies on the burden of AD in paediatric patients are available in literature, while data in adults is scant. The purpose of this study was to estimate the direct and indirect costs of moderate to severe AD in adult patients in Italy.METHODS: Patients with Eczema Area and Severity Index (EASI) score >20 were included in a multicentre, observational study conducted in six outpatient dermatology clinics throughout the national territory. Data were retrospectively gathered through a case report form investigating healthcare resources consumption, out-of-pocket expenses and patients' and caregivers' productivity loss. Descriptive statistics was used to illustrate data. Univariate generalized linear model with gamma distribution and identity function link was used to describe association between costs and disease severity.RESULTS: A total of 50 patients with a diagnosis of moderate-to-severe DA (EASI score ≥ 20), equal to 89% of the total, were included in the analysis. The total annual burden of the disease, direct and indirect costs, amounted to € 4,284 per patient; 19.3% accounted for direct medical costs, 19.9% for direct non-medical and 60.8% for indirect costs due to productivity loss.CONCLUSIONS: Moderate-to-severe AD in adults represents an important cost for the society imposing a high financial burden for the NHS, but even more for patients and caregivers. Results from this study may support identification of potential factors impacting on the choice of new therapeutic options to improve the clinical and economic management of this devastating disease.

U2 - 10.23736/S0392-0488.19.06430-7

DO - 10.23736/S0392-0488.19.06430-7

M3 - Article

C2 - 31525844

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

SN - 0392-0488

ER -